Overcoming doxorubicin-resistance in the NCI/ADR-RES model cancer cell line by novel anthracene-9,10-dione derivatives

Overcoming doxorubicin-resistance in the NCI/ADR-RES model cancer cell line by novel anthracene-9,10-dione derivatives 6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A Novel Class of Chromophore-Modified Antitumor Anthracene-9,10-diones: Synthesis and Antitumor Evaluations Synthesis and in vitro evaluation of 3-substituted-1-azaanthraquinones Synthesis and Cytotoxic Evaluation of Novel Spirohydantoin Derivatives of the Dihydrothieno[2,3-b]naphtho-4,9-dione System Design, Synthesis, and Cytotoxic Evaluation of Acyl Derivatives of 3-Aminonaphtho[2,3-b]thiophene-4,9-dione, a Quinone-Based System Synthesis and in vitro evaluation of 7-dialkylaminomethylbenzo[ g ]quinoxaline-5,10-diones Anthraquinone derivatives induce G2/M cell cycle arrest and apoptosis in NTUB1 cells Synthesis and cytotoxic properties of 4,11-bis[(aminoethyl)amino]anthra[2,3-b]thiophene-5,10-diones, novel analogues of antitumor anthracene-9,10-diones Annulation of substituted anthracene-9,10-diones yields promising selectively antiproliferative compounds New hydroxy-amido-anthraquinones as potential antineoplastic drugs.